Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 59651-524

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 59651-524). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg/2.5 mg (100 Capsules Bottle))

Label for Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP 5 mg/2.5 mg by Aurobindo Pharma Limited. The label indicates 100 capsules in the package, Rx only. It includes storage instructions, dosage information, and distributor details for Aurobindo Pharma USA, Inc. A barcode is present on the right side.*

FDA Label Image

Chemical Structure1 (Chlorclid Str1)

Chemical structure of Chlordiazepoxide Hydrochloride, showing its molecular arrangement with chlorine and hydrochloride components clearly marked.*

FDA Label Image

Chemical Structure2 (Chlorclid Str2)

Chemical structure diagram of Chlordiazepoxide Hydrochloride and Clidinium Bromide showing molecular connectivity, including phenyl rings and a bromide ion attached to the nitrogen-containing ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.